medical device investing Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider
pharmaceutical investing Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia
pharmaceutical investing Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
pharmaceutical investing Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
longevity investing Nova Leap Health Closes Brokered and Non-Brokered Private Placements For $1.71 million
Isodiol International Inc. Provides Update on Be Tru Wellness, Announces New Distribution Agreement With Threshold Enterprises
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
